-
12-O-tetradecanoyl phorbol-13-acetate (TPA) Workflows
2026-08-15
Build more interpretable PKC and ERK/MAPK experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from rapid phosphorylation assays to mechanistic cancer studies. This guide emphasizes timing, solvent controls, orthogonal readouts, and a practical way to use TPA alongside cisplatin-resistance research.
-
BNNC: Hypoxia-Activated Cyclin K Degradation
2026-08-14
The reference study introduces BNNC, a hypoxia-activated photomolecular glue that releases the Cyclin K degrader (R)-CR8 together with the phototherapeutic agent BSS-Et in tumors. Its combined degradation and phototherapy strategy enhanced DNA damage, apoptosis, and tumor growth control while addressing the tumor selectivity concerns of systemic Cyclin K degradation.
-
LGK-974: A Practical PORCN Inhibitor Workflow
2026-08-14
LGK-974 enables precise, upstream suppression of secreted Wnt ligands for cancer, bone, and pathway-mechanism studies. This guide connects dose selection, target-engagement readouts, model choice, and troubleshooting to practical workflows grounded in product specifications and recent in vivo evidence.
-
Fucoidan, Caveolin-1, and MCF-7 Breast Cancer
2026-08-13
A 2026 study identifies caveolin-1 downregulation as a potential component of Fucoidan activity in MCF-7 breast cancer cells. By combining cytotoxicity, membrane integrity, colony-formation, migration, and protein-expression assays, the work connects a marine sulfated polysaccharide with tumor-associated phenotypes while highlighting the need for causal and in vivo validation.
-
Chromogranin A Drives α-Synuclein Strain Formation
2026-08-13
A 2025 Cell Reports study identifies chromogranin A as a dense-core vesicle factor that promotes early α-synuclein aggregation and generates a distinct, protease-resistant fibril strain. The findings connect presynaptic pathology with synaptic dysfunction and suggest that vesicular matrix proteins influence how α-synuclein pathology begins and spreads.
-
Stress, CerS6, and Liver Mitochondrial Injury
2026-08-12
Liu et al. identify CerS6-derived C16:0 ceramide as a mechanistic link between corticosterone-associated stress and mitochondrial injury in hepatocytes. Their combined rat, cell-culture, mitochondrial fractionation, LC–MS/MS, pathway-inhibition, and gene-silencing strategy provides a useful framework for studying stress-related lipid remodeling while emphasizing the need to preserve proteins and phosphorylation signals during sample processing.
-
HNF4A-AS1, Lipid Metabolism, and Sorafenib Resistance
2026-08-12
The 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a suppressor of sorafenib resistance in hepatocellular carcinoma by linking m6A-dependent RNA regulation to PUFA availability and ferroptosis. Its integrated database, lipidomic, mechanistic, organoid, and xenograft analyses provide a framework for studying metabolic determinants of treatment response.
-
Praeruptorin A: An Assay-First Research Framework
2026-08-11
Praeruptorin A is an angular pyranocoumarin compound with linked effects on iron handling, inflammation, barrier integrity, and tumor-cell invasion. This assay-first guide explains how to translate its DMT1–ferroptosis findings into better cardiomyopathy, ulcerative colitis, and metastasis research decisions.
-
Glabridin–Gold(I) Complex Enhances Antitumor Immunity
2026-08-11
The reference study develops complex 6d, which combines an N-heterocyclic carbene gold(I) center with glabridin to target TrxR and MAPK-linked immunosuppressive biology. In liver cancer models, the compound promoted dendritic-cell maturation, reduced suppressive immune populations, lowered PD-L1 expression, and enhanced granzyme B production, supporting a dual strategy for remodeling the tumor immune microenvironment.
-
Protein Integrity: From Lysis to Epigenetic Memory
2026-08-10
Environmental disruption can reshape developmental outcomes by compromising protein integrity before epigenetic programs are established. This thought-leadership article translates that insight into practical sample-preservation guidance, showing how an EDTA-free protease inhibitor strategy can protect mechanistic readouts without disturbing divalent-cation-dependent assays.
-
Phosbind Acrylamide: Mapping ISR Phosphorylation
2026-08-09
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis by resolving phosphorylation-dependent mobility shifts in SDS-PAGE. This guide connects the reagent to coronavirus integrated stress response research and shows how to interpret gel-based evidence alongside pathway-specific assays.
-
Melatonin–SCNF Hydrogel for Atopic Dermatitis
2026-08-08
This study developed a melatonin-loaded sacchachitin nanofiber hydrogel as a non-steroidal topical platform for atopic dermatitis. In a DNCB-induced NC/Nga mouse model, the formulation reduced disease severity, epidermal hyperplasia, mast cell infiltration, and Th2-associated biomarkers while retaining melatonin stability and hydrogel mechanical properties.
-
Fluorescein TSA Fluorescence System Kit Guide
2026-08-07
The Fluorescein TSA Fluorescence System Kit enables high-sensitivity detection of scarce proteins and nucleic acids in fixed samples. This guide connects its deposition chemistry to biomarker-selection decisions informed by miR-3180 research in hepatocellular carcinoma.
-
Z-DEVD-FMK: Caspase-3 Inhibitor Workflows for Apoptosis & Ne
2026-08-07
Z-DEVD-FMK empowers researchers to dissect apoptosis and neuroprotection by irreversibly inhibiting caspase-3 and calpain pathways. This article translates cutting-edge reference findings into detailed, actionable protocols and troubleshooting strategies for advanced cell death assays.
-
Structural Insights into Nipah Virus Polymerase Complex Asse
2026-08-06
This study elucidates the high-resolution structure of the Nipah virus (NiV) polymerase complex, revealing the detailed organization of its RNA-dependent RNA polymerase and phosphoprotein components. These findings clarify the molecular interactions essential for viral RNA synthesis, providing a structural basis for antiviral drug development targeting NiV and related zoonotic RNA viruses.